Treating hospital-acquired pneumonia
This article reviews telavancin’s pharmacological characteristics as evidenced by clinical trials and studies, to provide a detailed picture of its use in the management of hospital-acquired pneumonia
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
More News: Clinical Trials | Drugs & Pharmacology | Hospital Management | Hospitals | Pneumonia | Study